Michael Ehlers
January 8, 2021 08:00 AM EST
Startups

Michael Ehlers is bet­ting $40M that an AI out­fit has fig­ured out how to beat the block­buster IL-2 chal­lenge

John Carroll

Editor & Founder

Sanofi was so in­trigued by the prospect of fig­ur­ing out a break­through on IL-2 in can­cer that Paul Hud­son re­cent­ly en­gi­neered a $2.5 bil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times